US Stock MarketDetailed Quotes
UTMD Utah Medical Products
- 64.640
- +0.550+0.86%
Close Nov 4 16:00 ET
- 64.640
- 0.0000.00%
Post 18:45 ET
222.40MMarket Cap15.11P/E (TTM)
64.695High63.870Low25.97KVolume63.870Open64.090Pre Close1.67MTurnover0.87%Turnover Ratio14.14P/E (Static)3.44MShares86.40252wk High1.79P/B192.62MFloat Cap63.38052wk Low1.20Dividend TTM2.98MShs Float126.334Historical High1.86%Div YieldTTM1.29%Amplitude2.826Historical Low64.250Avg Price1Lot Size
Utah Medical Products Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -43.78%2.76M | -23.70%5.28M | 5.36%22.28M | -6.13%5.33M | -8.37%5.12M | 1.68%4.91M | 37.04%6.92M | -0.26%21.15M | 13.90%5.68M | -6.71%5.59M |
| Net income from continuing operations | -17.79%3.45M | -6.12%3.96M | 0.98%16.64M | -5.91%4.29M | -8.06%3.94M | 2.34%4.2M | 19.24%4.21M | 11.39%16.47M | 10.24%4.56M | 1.76%4.28M |
| Depreciation and amortization | -61.05%693K | -61.28%683K | -10.08%6.37M | -40.64%1.04M | 2.29%1.79M | 0.17%1.78M | -2.49%1.76M | -2.77%7.08M | -1.18%1.75M | -4.64%1.75M |
| Deferred tax | -26.77%-161K | -18,200.00%-183K | -72.41%-681K | -3,021.43%-409K | -17.07%-144K | 10.56%-127K | 99.31%-1K | -645.28%-395K | -85.42%14K | 30.11%-123K |
| Change In working capital | -32.74%-1.28M | -15.56%749K | 89.53%-233K | 148.46%345K | -45.38%-503K | 0.21%-962K | 534.80%887K | -121.27%-2.23M | 32.89%-712K | -543.59%-346K |
| -Change in receivables | -132.55%-83K | -111.96%-214K | 532.38%2.27M | -74.34%137K | 107.67%89K | -62.50%255K | 409.52%1.79M | 53.54%-525K | 262.80%534K | -307.37%-1.16M |
| -Change in inventory | 205.59%170K | 125.00%271K | 71.53%-670K | 188.54%255K | 128.19%320K | -33.06%-161K | -33.99%-1.08M | -385.15%-2.35M | 11.11%-288K | -380.93%-1.14M |
| -Change in prepaid assets | 700.00%132K | -448.00%-87K | 170.31%45K | 144.07%26K | -61.90%16K | -135.48%-22K | 122.94%25K | 20.99%-64K | -28.26%-59K | 300.00%42K |
| -Change in payables and accrued expense | -44.68%-1.5M | 396.18%779K | -362.29%-1.88M | 91.88%-73K | -148.64%-928K | 34.76%-1.03M | -87.85%157K | 3.77%716K | -147.66%-899K | 207.74%1.91M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -43.78%2.76M | -23.70%5.28M | 5.36%22.28M | -6.13%5.33M | -8.37%5.12M | 1.68%4.91M | 37.04%6.92M | -0.26%21.15M | 13.90%5.68M | -6.71%5.59M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 64.06%-115K | 111.63%5K | 21.88%-639K | -136.84%-90K | 42.06%-186K | -44.14%-320K | 81.86%-43K | -48.19%-818K | 84.98%-38K | -316.88%-321K |
| Capital expenditure reported | 65.63%-110K | 48.84%-22K | 21.88%-639K | ---- | ---- | -44.14%-320K | 81.86%-43K | ---818K | ---- | ---- |
| Net PPE purchase and sale | --0 | --27K | ---- | ---- | ---549K | --0 | --0 | ---- | ---- | ---- |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 64.06%-115K | 111.63%5K | 21.88%-639K | -136.84%-90K | 42.06%-186K | -44.14%-320K | 81.86%-43K | -48.19%-818K | 84.98%-38K | -316.88%-321K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -611.88%-7.19M | -279.69%-3.98M | 24.05%-4.17M | -16.41%-1.07M | -0.29%-1.04M | 71.56%-1.01M | -5,621.05%-1.05M | 49.71%-5.48M | 88.60%-920K | -21.41%-1.03M |
| Net common stock issuance | ---6.4M | ---2.99M | --0 | --0 | --0 | --0 | --0 | ---2.5M | --0 | --0 |
| Cash dividends paid | -1.03%-1.08M | -1.78%-1.09M | -35.38%-4.28M | -1.90%-1.07M | -1.81%-1.07M | -0.94%-1.07M | ---1.07M | 72.41%-3.16M | 87.41%-1.05M | -1.25%-1.05M |
| Proceeds from stock option exercised by employees | 390.00%294K | 357.14%96K | -32.76%117K | --0 | 80.00%36K | 1,400.00%60K | 10.53%21K | -68.93%174K | -53.05%131K | -89.42%20K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -611.88%-7.19M | -279.69%-3.98M | 24.05%-4.17M | -16.41%-1.07M | -0.29%-1.04M | 71.56%-1.01M | -5,621.05%-1.05M | 49.71%-5.48M | 88.60%-920K | -21.41%-1.03M |
| Net cash flow | ||||||||||
| Beginning cash position | 15.94%93.81M | 23.74%92.87M | 23.09%75.05M | 26.90%88.21M | 27.78%84.62M | 22.83%80.91M | 23.09%75.05M | 18.19%60.97M | 8.07%69.51M | 11.29%66.22M |
| Current changes in cash | -226.79%-4.54M | -77.71%1.3M | 17.73%17.48M | -11.67%4.17M | -7.93%3.9M | 238.34%3.58M | 20.61%5.82M | 52.32%14.85M | 241.55%4.72M | -16.35%4.24M |
| Effect of exchange rate changes | -137.10%-46K | -1,067.57%-358K | 144.20%339K | -40.42%488K | 67.33%-310K | 117.51%124K | -47.89%37K | -111.88%-767K | 7,545.45%819K | -281.12%-949K |
| End cash Position | 5.44%89.22M | 15.94%93.81M | 23.74%92.87M | 23.74%92.87M | 26.90%88.21M | 27.78%84.62M | 22.83%80.91M | 23.09%75.05M | 23.09%75.05M | 8.07%69.51M |
| Free cash flow | -42.37%2.65M | -23.54%5.25M | 6.46%21.64M | -7.09%5.24M | -6.32%4.94M | -0.37%4.59M | 42.90%6.87M | -1.56%20.33M | 19.18%5.64M | -10.92%5.27M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data